瑞替普酶成功治疗大面积肺血栓栓塞症：病例系列
Successful Treatment of Massive Pulmonary Thromboembolism with Reteplase: Case Series.
作者信息
Ghobadi Hassan, Amirajam Zahra, Habibzadeh Afshin
机构信息
Department of Internal Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
出版信息
Tanaffos. 2018 Jan;17(1):53-56.
Abstract
Massive pulmonary thromboembolism (PTE) has an increased risk of mortality. Thrombolytic therapy is the accepted treatment. Reteplase, a variant of tissue plasminogen activator, has been used in acute myocardial infarction with acceptable safety and efficacy, but studies in massive PTE are rare. In this study we report five cases of successful treatment of massive PTE with reteplase.
摘要
大面积肺血栓栓塞症（PTE）的死亡风险增加。溶栓治疗是公认的治疗方法。瑞替普酶是组织型纤溶酶原激活剂的一种变体，已用于急性心肌梗死，安全性和疗效尚可，但在大面积PTE方面的研究较少。在本研究中，我们报告了5例使用瑞替普酶成功治疗大面积PTE的病例。
相似文献
1
Successful Treatment of Massive Pulmonary Thromboembolism with Reteplase: Case Series.瑞替普酶成功治疗大面积肺血栓栓塞症：病例系列
Tanaffos. 2018 Jan;17(1):53-56.
2
Reteplase: a review of its use in the management of thrombotic occlusive disorders.瑞替普酶：用于血栓闭塞性疾病管理的综述
Am J Cardiovasc Drugs. 2006;6(4):265-85. doi: 10.2165/00129784-200606040-00007.
3
Spotlight on reteplase in thrombotic occlusive disorders.瑞替普酶在血栓闭塞性疾病中的应用聚焦
BioDrugs. 2007;21(1):65-8. doi: 10.2165/00063030-200721010-00008.
4
[Clinical efficacy and safety of thrombolytic treatment with reteplase in patients with intermediate-risk acute pulmonary embolism].瑞替普酶溶栓治疗中危急性肺栓塞患者的临床疗效及安全性
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Apr 24;45(4):314-317. doi: 10.3760/cma.j.issn.0253-3758.2017.04.011.
5
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.双推注瑞替普酶（重组纤溶酶原激活剂）与前负荷加速阿替普酶（重组组织型纤溶酶原激活剂）用于急性心肌梗死患者冠状动脉溶栓的随机对照比较。RAPID II研究组。
Circulation. 1996 Sep 1;94(5):891-8. doi: 10.1161/01.cir.94.5.891.
6
[Efficacy of thrombolytic therapy using reteplase in cases with acute ST-segment elevation myocardial infarction: results from a multicenter clinical trial].瑞替普酶溶栓治疗急性ST段抬高型心肌梗死的疗效：一项多中心临床试验结果
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Sep 24;44(9):766-770. doi: 10.3760/cma.j.issn.0253-3758.2016.09.007.
7
Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.双剂量瑞替普酶与阿替普酶静脉输注治疗大面积肺栓塞的血流动力学效应
Am Heart J. 1999 Jul;138(1 Pt 1):39-44. doi: 10.1016/s0002-8703(99)70243-7.
8
The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials.溶栓药物在心肌梗死治疗中的作用。比较临床试验。
Eur Heart J. 1996 Dec;17 Suppl F:9-15. doi: 10.1093/eurheartj/17.suppl_f.9.
9
[The changes of serum enzymes and cardiac troponin I in patients with acute pulmonary thromboembolism].急性肺血栓栓塞症患者血清酶及心肌肌钙蛋白I的变化
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Sep;30(9):667-72.
10
[The clinical features of 516 patients with acute pulmonary thromboembolism].516例急性肺血栓栓塞症患者的临床特征
Zhonghua Yi Xue Za Zhi. 2006 Aug 22;86(31):2161-5.
引用本文的文献
1
Intraoperative circulatory arrest secondary to high-risk pulmonary embolism. Case series and updated literature review.高危肺栓塞导致的术中循环骤停。病例系列及文献更新综述。
BMC Anesthesiol. 2023 Dec 18;23(1):415. doi: 10.1186/s12871-023-02370-z.
2
Thrombolysis with reteplase in acute pulmonary embolism.瑞替普酶用于急性肺栓塞的溶栓治疗。
Indian Heart J. 2019 Nov-Dec;71(6):464-467. doi: 10.1016/j.ihj.2019.09.011. Epub 2019 Sep 20.
3
Use of reteplase for thrombolysis in patients with massive pulmonary embolism diagnosed by bedside transthoracic echocardiography: A retrospective study of safety and efficacy.使用瑞替普酶对经床旁经胸超声心动图诊断为大面积肺栓塞的患者进行溶栓治疗：安全性和有效性的回顾性研究
J Family Med Prim Care. 2019 Oct 31;8(10):3155-3159. doi: 10.4103/jfmpc.jfmpc_512_19. eCollection 2019 Oct.
本文引用的文献
1
Outcome of surgical embolectomy in patients with massive pulmonary embolism with and without cardiopulmonary resuscitation.接受和未接受心肺复苏的大面积肺栓塞患者手术取栓的结果。
Kardiochir Torakochirurgia Pol. 2017 Dec;14(4):241-244. doi: 10.5114/kitp.2017.72228. Epub 2017 Dec 20.
2
[Clinical efficacy and safety of thrombolytic treatment with reteplase in patients with intermediate-risk acute pulmonary embolism].瑞替普酶溶栓治疗中危急性肺栓塞患者的临床疗效及安全性
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Apr 24;45(4):314-317. doi: 10.3760/cma.j.issn.0253-3758.2017.04.011.
3
Thrombolytic-plus-Anticoagulant Therapy versus Anticoagulant-Alone Therapy in Submassive Pulmonary Thromboembolism (TVASPE Study): A Randomized Clinical Trial.亚大面积肺血栓栓塞症的溶栓联合抗凝治疗与单纯抗凝治疗对比研究（TVASPE研究）：一项随机临床试验
J Tehran Heart Cent. 2014;9(3):104-8. Epub 2014 Jul 3.
4
[Pulmonary thromboembolism: incidence, physiopathology, diagnosis and treatment].[肺血栓栓塞症：发病率、病理生理学、诊断与治疗]
Tunis Med. 2014 Jul;92(7):435-47.
5
Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis.急性肺栓塞的全身溶栓治疗：一项系统评价和荟萃分析。
Eur Heart J. 2015 Mar 7;36(10):605-14. doi: 10.1093/eurheartj/ehu218. Epub 2014 Jun 10.
6
Early and late clinical outcomes of pulmonary embolectomy for acute massive pulmonary embolism.急性大面积肺栓塞取栓术的早期和晚期临床结局。
Ann Thorac Surg. 2010 Dec;90(6):1747-52. doi: 10.1016/j.athoracsur.2010.08.002.
7
Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).急性肺栓塞诊断与管理指南：欧洲心脏病学会（ESC）急性肺栓塞诊断与管理特别工作组
Eur Heart J. 2008 Sep;29(18):2276-315. doi: 10.1093/eurheartj/ehn310. Epub 2008 Aug 30.
8
Reteplase: a review of its use in the management of thrombotic occlusive disorders.瑞替普酶：用于血栓闭塞性疾病管理的综述
Am J Cardiovasc Drugs. 2006;6(4):265-85. doi: 10.2165/00129784-200606040-00007.
9
Life threatening massive pulmonary embolism treated with reteplase: a case report.
Crit Care Resusc. 2000 Dec;2(4):278-81.
10
Management of massive pulmonary embolism.大面积肺栓塞的管理
Circulation. 2005 Jul 12;112(2):e28-32. doi: 10.1161/CIRCULATIONAHA.105.551374.
Zotero 插件